S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis

J F Leal1, I Ferrer, C Blanco-Aparicio

  • 1Spanish National Cancer Research Center (CNIO), 3 Melchor Fernández Almagro St, Madrid 28029, Spain.

Carcinogenesis
|August 21, 2008
PubMed

Insights

Researchers identified S-adenosylhomocysteine hydrolase (SAHH) as a potential tumor suppressor. SAHH inactivation promotes cell proliferation resistance and affects tumor suppressor gene activity, with reduced SAHH found in many human tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tumor suppressor genes are critical in preventing cancer development.
  • Genome-wide screens are essential for identifying novel genes involved in cell proliferation.
  • S-adenosylhomocysteine hydrolase (SAHH) was previously identified as a potential tumor suppressor.

Purpose of the Study:

  • To investigate the role of SAHH in cell proliferation and tumor suppression.
  • To determine the impact of SAHH inactivation on key cell cycle regulators like p53 and p21(Cip1).
  • To analyze SAHH expression patterns in human tumors.

Main Methods:

  • Genome-wide loss-of-function genetic screen.
  • Short hairpin RNA (shRNA) screening.
  • Analysis of p53 transcriptional activity and p21(Cip1) induction.
  • Quantitative analysis of SAHH mRNA and protein levels in tumor tissues.

Main Results:

  • SAHH inactivation confers resistance to p53 and p16(INK4)-induced proliferation arrest.
  • SAHH inactivation inhibits p53 transcriptional activity and impairs DNA damage-induced p21(Cip1) transcription.
  • SAHH mRNA was lost in 50% of diverse human tumor tissues analyzed.
  • SAHH protein levels were altered in some colon cancers.

Conclusions:

  • SAHH functions as a potential tumor suppressor by regulating cell proliferation and responding to DNA damage.
  • Downregulation of SAHH is a frequent event in human cancers.
  • SAHH represents a promising, yet largely unexplored, target for cancer research.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...